CA2303598A1 - Dosage immunologique en tandem pour diagnostiquer le cancer - Google Patents
Dosage immunologique en tandem pour diagnostiquer le cancer Download PDFInfo
- Publication number
- CA2303598A1 CA2303598A1 CA 2303598 CA2303598A CA2303598A1 CA 2303598 A1 CA2303598 A1 CA 2303598A1 CA 2303598 CA2303598 CA 2303598 CA 2303598 A CA2303598 A CA 2303598A CA 2303598 A1 CA2303598 A1 CA 2303598A1
- Authority
- CA
- Canada
- Prior art keywords
- cancer
- breast cancer
- cellular
- ndp
- kinase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Hospice & Palliative Care (AREA)
- AIDS & HIV (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA 2303598 CA2303598C (fr) | 1999-03-30 | 2000-03-30 | Dosage immunologique en tandem pour diagnostiquer le cancer |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2,267,481 | 1999-03-30 | ||
CA002267481A CA2267481A1 (fr) | 1999-03-30 | 1999-03-30 | Interdependance critique : du role de l'oestrogene dans le cancer du sein a la sensibilite des femmes a l'infection par le vih |
CA 2303598 CA2303598C (fr) | 1999-03-30 | 2000-03-30 | Dosage immunologique en tandem pour diagnostiquer le cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2303598A1 true CA2303598A1 (fr) | 2000-09-11 |
CA2303598C CA2303598C (fr) | 2002-07-23 |
Family
ID=25680866
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2303598 Expired - Fee Related CA2303598C (fr) | 1999-03-30 | 2000-03-30 | Dosage immunologique en tandem pour diagnostiquer le cancer |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2303598C (fr) |
-
2000
- 2000-03-30 CA CA 2303598 patent/CA2303598C/fr not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2303598C (fr) | 2002-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0009484A (pt) | Imunoensaio em série para câncer | |
Sokoloff et al. | A dual‐monoclonal sandwich assay for prostate‐specific membrane antigen: Levels in tissues, seminal fluid and urine | |
Mikolajczyk et al. | Pro PSA: a more cancer specific form of prostate specific antigen for the early detection of prostate cancer | |
De Potter et al. | The expression of the neu oncogene product in breast lesions and in normal fetal and adult human tissues | |
AU2002211697B2 (en) | Non-invasive enzyme screen for tissue remodelling-associated conditions | |
Goldschneider et al. | Demonstration of terminal deoxynucleotidyl transferase in thymocytes by immunofluorescence. | |
Chenard et al. | High levels of stromelysin‐3 correlate with poor prognosis in patients with breast carcinoma | |
AU720802B2 (en) | Detection of cancer by assaying for cancer-specific antigens having linked oligosaccharides which are at least triantennary | |
WO2004065547A3 (fr) | Antigene associe au cancer du pancreas, anticorps correspondant et methodes de diagnostic et de traitement | |
JP2006311860A (ja) | 組織のリモデリングに関連した状態のための非観血的酵素スクリーン | |
Goldberg | Proteases in the evaluation of pancreatic function and pancreatic disease | |
CN109813893A (zh) | Cea检测试纸条及其制备方法、cea检测装置 | |
Jain et al. | Small integrin-binding proteins as serum markers for prostate cancer detection | |
US20030215900A1 (en) | Non-invasive enzyme screen for cancer | |
Alanen et al. | Immunohistochemical labelling for prostate–specific antigen in breast carcinomas | |
CA2303598A1 (fr) | Dosage immunologique en tandem pour diagnostiquer le cancer | |
Corey et al. | Characterization of 10 new monoclonal antibodies against prostate‐specific antigen by analysis of affinity, specificity and function in sandwich assays | |
CA2303505A1 (fr) | Anticorps monoclonal anti-leucine aminopeptidase stimulee par l'oestrogene | |
Griffiths et al. | The laboratory diagnosis of prostatic adenocarcinoma | |
Ban et al. | Immunologic markers and the diagnosis of prostatic cancer | |
Bogdanowicz et al. | Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia | |
US8481273B2 (en) | Perlecan fragments as biomarkers of bone stromal lysis | |
Ylätupa et al. | Enzyme immunoassay for quantification of tenascin in biologic samples | |
Barbauche et al. | Prognostic significance of autoantibodies to laminin in the sera of breast cancer patients: a preliminary report | |
WO2001065262A3 (fr) | Reactifs et methodes de detection des pathologies mammaires |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |